Current Concepts in Drug‐Induced Mitochondrial Toxicity

Mitochondria generate most of the cell's ATP and play key roles in fatty acid oxidation, steroid synthesis, heme synthesis, thermogenesis, calcium homeostasis, and apoptosis. With the development of new methods to study mitochondrial function, it is becoming clear that drug‐induced mitochondrial dysfunction is one of the causes of drug toxicity. Mitochondria can be impaired by drugs in a variety of ways. These include inhibition of oxidative phosphorylation, uncoupling of electron transport from ATP synthesis, irreversible opening of the mitochondrial permeability transition pore, inhibition of transporters within the mitochondrial inner membrane, increased oxidative stress, inhibition of the citric acid cycle, inhibition of fatty acid oxidation, and impairment of either mtDNA replication or mtDNA‐encoded protein synthesis. This unit provides an overview on the physiological roles of mitochondria and the mechanisms by which they can be adversely affected by drugs. Curr. Protoc. Toxicol. 40:2.15.1‐2.15.9. © 2009 by John Wiley & Sons, Inc.

[1]  L. Marroquin,et al.  Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. , 2008, Toxicology and applied pharmacology.

[2]  G. Labbe,et al.  Drug‐induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies , 2008, Fundamental & clinical pharmacology.

[3]  S. Carr,et al.  A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.

[4]  K. Wallace Mitochondrial off targets of drug therapy. , 2008, Trends in pharmacological sciences.

[5]  Tak W. Mak,et al.  Cytochrome c: functions beyond respiration , 2008, Nature Reviews Molecular Cell Biology.

[6]  J. Xu,et al.  In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  Fernando J. Pineda,et al.  Mitochondrial fission and fusion dynamics: the long and short of it , 2008, Cell Death and Differentiation.

[8]  R. Ferrante,et al.  Mitochondrial nuclear receptors and transcription factors: Who's minding the cell? , 2008, Journal of neuroscience research.

[9]  D. Green,et al.  How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? , 2008, Trends in cell biology.

[10]  Katie Chan,et al.  Drug‐Associated Mitochondrial Toxicity , 2008 .

[11]  L. Wojtczak,et al.  Basic Mitochondrial Physiology in Cell Viability and Death , 2008 .

[12]  E. McKee Assessing Mitochondrial Protein Synthesis in Drug Toxicity Screening , 2008 .

[13]  I. Scheffler Basic Molecular Biology of Mitochondrial Replication , 2008 .

[14]  A. D. Ronde,et al.  Mitochondrial Toxicity of Antiviral Drugs: A Challenge to Accurate Diagnosis , 2008 .

[15]  R. Capaldi,et al.  Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration. , 2007, Toxicology and applied pharmacology.

[16]  Yvonne Will,et al.  The significance of mitochondrial toxicity testing in drug development. , 2007, Drug discovery today.

[17]  P. Bottoni,et al.  The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. , 2007, American journal of physiology. Cell physiology.

[18]  U. Boelsterli,et al.  Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  I. Scheffler Mitochondrial Electron Transfer and Oxidative Phosphorylation , 2007 .

[20]  Yvonne Will,et al.  Strategies to reduce late-stage drug attrition due to mitochondrial toxicity , 2007, Expert review of molecular diagnostics.

[21]  E. Böttger,et al.  Visions & Reflections ( Minireview ) Antimicrobial agents targeting the ribosome : the issue of selectivity and toxicity lessons to be learned , 2007 .

[22]  B. Antonsson,et al.  A tale of two mitochondrial channels, MAC and PTP, in apoptosis , 2007, Apoptosis.

[23]  C. Chinopoulos,et al.  Bioenergetics and the formation of mitochondrial reactive oxygen species. , 2006, Trends in pharmacological sciences.

[24]  S. Krähenbühl,et al.  Toxicity of statins on rat skeletal muscle mitochondria , 2006, Cellular and Molecular Life Sciences CMLS.

[25]  D. Pessayre,et al.  The Anti-Inflammatory Drug, Nimesulide (4-Nitro-2-phenoxymethane-sulfoanilide), Uncouples Mitochondria and Induces Mitochondrial Permeability Transition in Human Hepatoma Cells: Protection by Albumin , 2006, Journal of Pharmacology and Experimental Therapeutics.

[26]  A. T. Bentley,et al.  Inhibition of Mammalian Mitochondrial Protein Synthesis by Oxazolidinones , 2006, Antimicrobial Agents and Chemotherapy.

[27]  Y. Masubuchi,et al.  Mitochondrial permeability transition as a potential determinant of hepatotoxicity of antidiabetic thiazolidinediones. , 2006, Toxicology.

[28]  G. Kroemer,et al.  Apoptosis-inducing factor: vital and lethal. , 2006, Trends in cell biology.

[29]  Katie Chan,et al.  Drug-induced mitochondrial toxicity , 2005, Expert opinion on drug metabolism & toxicology.

[30]  U. Boelsterli,et al.  Mitochondrial permeability transition as a source of superoxide anion induced by the nitroaromatic drug nimesulide in vitro. , 2005, Free radical biology & medicine.

[31]  D. Green,et al.  Apoptotic Pathways: Ten Minutes to Dead , 2005, Cell.

[32]  Michael Roden,et al.  Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex I , 2004, Journal of Pharmacology and Experimental Therapeutics.

[33]  N. Kaplowitz,et al.  Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. , 2004, Biochemical pharmacology.

[34]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[35]  H. Kusuhara,et al.  Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. , 2003, Molecular pharmacology.

[36]  Bradford W. Gibson,et al.  Characterization of the human heart mitochondrial proteome , 2003, Nature Biotechnology.

[37]  K. Penttilä,et al.  Effects of entacapone and tolcapone on mitochondrial membrane potential. , 2002, European journal of pharmacology.

[38]  L. Schwartz,et al.  Effects of troglitazone on HepG2 viability and mitochondrial function. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  Y. Masubuchi,et al.  Role of mitochondrial permeability transition in diclofenac‐induced hepatocyte injury in rats , 2002, Hepatology.

[40]  K. Wallace,et al.  The effect of peroxisome proliferators on mitochondrial bioenergetics. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  H. Möller,et al.  Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics , 1997, Molecular and Cellular Biochemistry.

[42]  G. Barlovatz-Meimon,et al.  Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells , 1997, Journal of the Neurological Sciences.

[43]  J. Casida,et al.  Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone. , 1990, Biochemical and biophysical research communications.

[44]  M. Weiner,et al.  Mechanism of action of agents which uncouple oxidative phosphorylation: direct correlation between proton-carrying and respiratory-releasing properties using rat liver mitochondria. , 1975, Biochimica et biophysica acta.

[45]  A. Psarra,et al.  Nuclear receptors and other nuclear transcription factors in mitochondria: regulatory molecules in a new environment. , 2008, Biochimica et biophysica acta.

[46]  Lorenzo Galluzzi,et al.  Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.

[47]  U. Boelsterli Disruption of Mitochondrial Function and Mitochondria-Mediated Toxicity , 2007 .

[48]  K. Wallace,et al.  Adriamycin-induced oxidative mitochondrial cardiotoxicity , 2006, Cell Biology and Toxicology.

[49]  A. Starkov,et al.  Mitochondrial targets of drug toxicity. , 2000, Annual review of pharmacology and toxicology.

[50]  C. Liébecq,et al.  The toxicity of fluoroacetate and the tricarboxylic acid cycle. 1949. , 1989, Biochimica et biophysica acta.